Patent: 10,307,483
✉ Email this page to a colleague
Summary for Patent: 10,307,483
| Title: | Pharmaceutical formulations and methods of making the same |
| Abstract: | The invention relates to the formulation of pharmaceutical compositions of etanercept. The invention also relates to methods of removing buffer and of formulating pharmaceutical compositions of etanercept. |
| Inventor(s): | Goss; Monica (Newbury Park, CA), Ball; Nicole (Thousand Oaks, CA) |
| Assignee: | AMGEN INC. (Thousand Oaks, CA) |
| Application Number: | 15/958,261 |
| Patent Claims: | see list of patent claims |
Details for Patent 10,307,483
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Immunex Corporation | ENBREL | etanercept | For Injection | 103795 | November 02, 1998 | ⤷ Start Trial | 2038-04-20 |
| Immunex Corporation | ENBREL | etanercept | For Injection | 103795 | May 27, 1999 | ⤷ Start Trial | 2038-04-20 |
| Immunex Corporation | ENBREL | etanercept | Injection | 103795 | September 27, 2004 | ⤷ Start Trial | 2038-04-20 |
| Immunex Corporation | ENBREL | etanercept | Injection | 103795 | February 01, 2007 | ⤷ Start Trial | 2038-04-20 |
| Immunex Corporation | ENBREL MINI | etanercept | Injection | 103795 | September 14, 2017 | ⤷ Start Trial | 2038-04-20 |
| Immunex Corporation | ENBREL | etanercept | Injection | 103795 | ⤷ Start Trial | 2038-04-20 | |
| Immunex Corporation | ENBREL | etanercept | Injection | 103795 | March 05, 2020 | ⤷ Start Trial | 2038-04-20 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 10,307,483
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2018075818 | ⤷ Start Trial |
| United States of America | 11491223 | ⤷ Start Trial |
| United States of America | 12214013 | ⤷ Start Trial |
| United States of America | 2018110856 | ⤷ Start Trial |
| United States of America | 2018256718 | ⤷ Start Trial |
| United States of America | 2019022217 | ⤷ Start Trial |
| United States of America | 2023080571 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
